Rankings
▼
Calendar
PHAT Q2 2023 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PHAT
Phathom Pharmaceuticals, Inc.
$891M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$123,000
Operating Income
-$32M
Net Income
-$41M
EPS (Diluted)
$-0.84
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$265M
Total Liabilities
$247M
Stockholders' Equity
$18M
Cash & Equivalents
$249M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$123,000
-$149,000
+17.4%
Operating Income
-$32M
-$45M
+30.1%
Net Income
-$41M
-$51M
+19.6%
← FY 2023
All Quarters
Q3 2023 →